Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2- and TET2-Mutant Acute Myeloid Leukemia.
联合靶向治疗可破坏 IDH2 和 TET2 突变型急性髓系白血病中的异常致癌信号传导并逆转表观遗传功能障碍
期刊:Cancer Discovery
影响因子:33.3
doi:10.1158/2159-8290.CD-16-1049
Shih Alan H, Meydan Cem, Shank Kaitlyn, Garrett-Bakelman Francine E, Ward Patrick S, Intlekofer Andrew M, Nazir Abbas, Stein Eytan M, Knapp Kristina, Glass Jacob, Travins Jeremy, Straley Kim, Gliser Camelia, Mason Christopher E, Yen Katharine, Thompson Craig B, Melnick Ari, Levine Ross L
